J.O. Emembolu

No ORCID on file · 4 papers in corpus
article 2011
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.02.013

ObjectivesThe levonorgestrel (LNG) intrauterine system (LNG-IUS) has been shown to improve symptoms in women with minimal to moderate endometriosis. The precise mechanism for this is unknown. We hypothesized that this involves alteration in…

article 2011
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.09.007

ObjectivesMirena® has been shown to improve symptoms in women with minimal to moderate endometriosis. The precise mechanisms for this have not been thoroughly investigated. We investigate here one possible mechanism-alteration in the number…

article 2005
·doi:10.1097/01.ogx.0000167406.63373.53

Most treatments used to date for endometriosis cause systemic side effects that not only may reduce compliance, but also preclude their long-term use. The levonorgestrel intrauterine system, which delivers the progestogen levonorgestrel dir…

article 2004
Human Reproduction ·doi:10.1093/humrep/deh650

BACKGROUND: Side-effects and choice of drugs influence compliance during treatment for endometriosis. Progestogen administered by a device with a 5-year lifespan, has been shown to be an effective medical alternative with several advantages…